Exhibit
31.1

Certification
of Chief Executive Officer

Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002

I,
E. Gerald Kay certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Integrated BioPharma, Inc.;2.Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;3.Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;4.The
registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:a)
Designedsuch disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;b)  Designedsuch
internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;c)
Evaluatedthe effectiveness of the registrant's disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the
end of the period covered by this report based on such evaluation; andd)
Disclosedin this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is
reasonably likely to materially affect, the registrant's internal control over financial reporting.5.The
registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or
persons performing the equivalent functions):a)  Allsignificant
deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial
information; andb)  Anyfraud, whether
or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.

|Date: November 15, 2007 |  | By: /s/E. Gerald Kay           
|----------------------- |  | -------------------------------
|                        |  | Name: E. Gerald Kay            
|                        |  | Title:  Chief Executive Officer